NCT00922441View on ClinicalTrials.gov

A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Essential Hypertension
Interventions
DRUG

Fimasartan 60 mg group

Fimasartan 60 mg

DRUG

Fimasartan 120 mg group

Fimasartan 120 mg

DRUG

Reference (Valsartan 80 mg) group

Reference (Valsartan 80 mg)

Sponsors

Collaborators (1)

Catholic Medical Center
All Listed Sponsors
collaborator

Seoul National University Hospital

OTHER

collaborator

Kyungpook National University Hospital

OTHER

collaborator

Catholic Medical Center

OTHER

collaborator

Inje University

OTHER

collaborator

Chonnam National University Hospital

OTHER

lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY

NCT00922441 - A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension | Biotech Hunter | Biotech Hunter